Management of Neuropsychiatric Symptoms in People with Dementia (original) (raw)

Neuropsychiatric symptoms in dementia: Importance and treatment considerations

Sally Sharp

International Review of Psychiatry, 2008

View PDFchevron_right

Neuropsychiatric symptoms in dementia: Importance and treatment considerations Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College Introduction: Frequency and importance of dementia

Sally Sharp

View PDFchevron_right

Antipsychotics in Alzheimer's disease: A critical analysis

Eduardo Marques da Silva

Dementia & Neuropsychologia, 2011

View PDFchevron_right

Antipsychotics in Alzheimer's disease

Eduardo Marques da Silva

2011

View PDFchevron_right

Managing agitation in Alzheimer's disease and related disorders

Linda Hershey MD, PhD FAAN FANA

View PDFchevron_right

ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia

Dilip Jeste, Dan Blazer

Neuropsychopharmacology, 2008

View PDFchevron_right

Treatment of agitation in dementia

Anton Porsteinsson

New directions for mental health services, 1997

View PDFchevron_right

Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease

Paulo Bertolucci

Journal of the Neurological Sciences, 2014

View PDFchevron_right

Antidepressants for agitation and psychosis in patients with dementia

quynh bui

American family physician, 2012

View PDFchevron_right

A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD)

Maree Donna Simpson

Pharmacy

View PDFchevron_right

Medications used in dementia: a review of evidence

Chathurie U Suraweera

Sri Lanka Journal of Psychiatry, 2015

View PDFchevron_right

Pharmacological management of behavioural and psychological disturbance in dementia

John Wattis

Human Psychopharmacology: Clinical and Experimental, 2006

View PDFchevron_right

A preclinical screen to evaluate pharmacotherapies for the treatment of agitation in dementia

Deaglan Page

Behavioural Pharmacology, 2017

View PDFchevron_right

Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial

Cornelius Katona

PLoS ONE, 2012

View PDFchevron_right

Pharmacological Treatment of Psychosis and Agitation in Elderly Patients with Dementia

Anne Bailey

Drugs & Aging, 2002

View PDFchevron_right

Alternative pharmacological treatment options for agitation in Alzheimer’s disease

B. Imbimbo

Geriatric Care, 2015

View PDFchevron_right

Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review

Annie Guerin

Journal of Alzheimer's Disease

View PDFchevron_right

A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)

Anne Corbett

Journal of the American Medical Directors Association, 2015

View PDFchevron_right

Antipsychotics for behavioral and psychiatric symptoms of dementia: a reaudit in a specialist inpatient service

Camilla Haw

International Psychogeriatrics, 2014

View PDFchevron_right

Comparison of the Efficacy of New and Conventional Antipsychotic Drugs in the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)

Pietro Gareri

Archives of Gerontology and Geriatrics, 2004

View PDFchevron_right

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease

B. Imbimbo

Expert opinion on pharmacotherapy, 2015

View PDFchevron_right

Pharmacological Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD) in Nursing Homes: Development of Practice Recommendations in a Swiss Canton

Olivier Bugnon

Journal of the American Medical Directors Association, 2008

View PDFchevron_right

Can pharmacotherapy effectively reduce Alzheimer’s related agitation?

Madia LOZUPONE

Expert Opinion on Pharmacotherapy, 2020

View PDFchevron_right

Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia

Barbara Messinger-Rapport

JAMA, 2005

View PDFchevron_right

Behavioural and Psychological Problems in Dementia

Suprakash Chaudhury

Acta Scientific Medical Sciences, 2020

View PDFchevron_right

Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease

Carol Dillon

Current Psychopharmacology, 2014

View PDFchevron_right

Mood stabilizers in Alzheimer’s disease: symptomatic and neuroprotective rationales

Anton Porsteinsson

Advanced Drug Delivery Reviews, 2002

View PDFchevron_right

Treatment of behavioral and psychological symptoms of Alzheimer's disease

Blanka Klimova

Current treatment options in neurology, 2012

View PDFchevron_right

Treating Neuropsychiatric Symptoms of Alzheimer's disease: un update

Grazia D'Onofrio

International Journal of Geriatric Psychiatry, 2019

View PDFchevron_right

Paradoxical side effect in treatment with antipsychotics for aggression/agitation and psychosis in dementia: case-series

Tudor Florea

BULLETIN OF INTEGRATIVE PSYCHIATRY, 2020

View PDFchevron_right

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

jeffrey lieberman

New England Journal of Medicine, 2006

View PDFchevron_right

Role of antipsychotics for treating behavioral and psychological symptoms of dementia

Kai Zhen Yap

World Journal of Pharmacology, 2014

View PDFchevron_right